Group 1 - The core viewpoint of the news highlights the performance of Qianhai Kaiyuan Medical Health A and C funds, which experienced declines of 1.82% and 1.83% respectively in August, while the Shanghai Composite Index rose by 7.97% during the same period [1][2] - Since their inception on January 19, 2018, the cumulative returns for Qianhai Kaiyuan Medical Health A and C funds are 37.51% and 36.47% respectively, with a decline of 10.71% and 10.98% over the past three years [1] - As of June 30, 2025, the total scale of Qianhai Kaiyuan Medical Health A and C funds is 1.011 billion yuan [1] Group 2 - The top ten holdings of Qianhai Kaiyuan Medical Health A/C funds include companies such as Sanofi, Dizh Medical, Innovent Biologics, and others [1] - The fund is currently managed by Fan Jie, who has been with Qianhai Kaiyuan Fund Management Company since 2014 and has held various positions including research analyst and investment manager [1]
前海开源医疗健康8月份逆势下跌1.8% 沪指涨7.97%
Zhong Guo Jing Ji Wang·2025-09-02 08:13